Literature DB >> 2901554

Urokinase versus tissue plasminogen activator in pulmonary embolism.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901554

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Thrombolytic therapy for the treatment of acute pulmonary embolism.

Authors:  D R Anderson; M N Levine
Journal:  CMAJ       Date:  1992-04-15       Impact factor: 8.262

Review 2.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

3.  Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolism.

Authors:  G Meyer; M A Collignon; F Guinet; A A Jeffrey; L Barritault; H Sors
Journal:  Eur J Nucl Med       Date:  1990

4.  Mechanical breakdown and thrombolysis in subacute massive pulmonary embolism: A prospective trial.

Authors:  Bishav Mohan; Shibba Takkar Chhabra; Naved Aslam; Gurpreet Singh Wander; Naresh Kumar Sood; Sumati Verma; Anil Kumar Mehra; Sarit Sharma
Journal:  World J Cardiol       Date:  2013-05-26

Review 5.  Use of thrombolytic drugs in non-coronary disorders.

Authors:  M Verstraete
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

Review 6.  Pulmonary embolism--the role of thrombolytic therapy in its management.

Authors:  R S More; A Chauhan
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

7.  Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism.

Authors:  Yaoqian Cao; Haiyan Zhao; Wanpeng Gao; Yan Wang; Jie Cao
Journal:  Patient Prefer Adherence       Date:  2014-02-28       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.